1-Butanone, 4-(3-methyl-1-piperidinyl)-1-(2,4,6-trimethoxyphenyl)-, butanedioate (1:1) | 138230-22-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-Butanone, 4-(3-methyl-1-piperidinyl)-1-(2,4,6-trimethoxyphenyl)-, butanedioate (1:1)
• 英文别名: butanedioic acid;4-(3-methylpiperidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one
• CAS: 138230-22-5
• 化学式: C23H35NO8
• 分子量: 453.5
• InChiKey: DNEQGHONGAQMLP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.34
• 重原子数：
  32
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  123
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• [EN] NERVE DAMAGE<br/>[FR] ATTEINTE D'UN NERF
  申请人：ROELANTS IVO

  公开号：WO2005107744A1

  公开（公告）日：2005-11-17

  Present invention is directed to a novel medicament for medical treatment of nerve compression or nerve entrapment, such as carpal tunnel syndrome (CTS) or ulnar tunnel syndrome (UTS). More particularly it involves the use of aminoketones derivatives of phloroglucinol, to prevent, retard and ameliorate a nerve compression, a nerve entrapment or traumatic or physical nerve injury and the associated syndromes or axonal degeneration. Such aminoketone derivatives are preferably 2’,4’,6’-triemthoxy-4 (1-pyrrolidinyl) butyrophenone or pharmacologically acceptable salts and/or functional derivatives thereof. The medicament to prevent, retard and ameliorate a nerve compression, nerve entrapment or physical nerve injury syndromes can furthermore comprise magnesium (Mg), its pharmacologically acceptable salt or its derivatives, such as magnesium oxide, magnesium aspartate, magnesium sulphate, magnesium citrate chelated magnesium, magnesium EAP in an amount sufficient to treat, to prevent, to retard, to ameliorate of to cure physical or traumatic nerve injury, nerve compression or nerve entrapment and the associated syndromes or axonal degeneration.